Immedica acquires the rights for additional Ophthalmology products for European countries


Immedica Pharma AB (Immedica) has acquired rights from Novartis to five ophthalmology products involving indications for the treatment of glaucoma and inflammatory conditions of the eye, in certain European countries. The deal encompasses commercial and distribution rights and intellectual property for the five products in the territories. All five products are part of standard pharmaceutical […]